These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1676091)

  • 1. Thyroid-associated eye disease: pathophysiology.
    Weetman AP
    Lancet; 1991 Jul; 338(8758):25-8. PubMed ID: 1676091
    [No Abstract]   [Full Text] [Related]  

  • 2. Graves' ophthalmopathy: search for shared autoantigen(s) continues.
    Bartalena L
    J Endocrinol Invest; 2005 May; 28(5):396-7. PubMed ID: 16075919
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological reactivity of recombinant 1D autoantigen and its expression in human thyroid and eye muscle tissue: a possible autoantigenic link in Graves' patients.
    Kromminga A; Hagel C; Arndt R; Schuppert F
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2817-23. PubMed ID: 9709953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of human autoimmune thyroid disease--1992.
    Davies TF; Kendler DL
    Monogr Pathol; 1993; (35):103-17. PubMed ID: 8502247
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease.
    Bahn RS
    J Clin Endocrinol Metab; 2003 May; 88(5):1939-46. PubMed ID: 12727937
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral blood T lymphocyte sensitization to thyroid microsomal antigen from patients with Graves' disease negative for circulating anti-thyroid microsomal antibodies.
    Matsubayashi S; Sakatsume Y; Kasuga Y; Akasu F; Tamai H; Volpé R
    Clin Invest Med; 1990 Dec; 13(6):339-42. PubMed ID: 2078913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Graves' disease.
    Pittman CS; Menefee JK
    Hosp Pract (Off Ed); 1987 May; 22(5):147-57, 162-4. PubMed ID: 3106370
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
    Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
    Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease.
    Dayan CM; Londei M; Corcoran AE; Grubeck-Loebenstein B; James RF; Rapoport B; Feldmann M
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7415-9. PubMed ID: 1714602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current understanding of pathogenesis of Graves ophthalmopathy].
    Ando T; Eguchi K
    Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
    Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
    Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.
    Weetman AP; Fells P; Shine B
    Br J Ophthalmol; 1989 May; 73(5):323-7. PubMed ID: 2786428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-tolerance and autoimmunity in the thyroid.
    Allison AC
    N Engl J Med; 1976 Oct; 295(15):821-7. PubMed ID: 183115
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic and genetic factors in autoimmune diseases.
    Shoenfeld Y; Schwartz RS
    N Engl J Med; 1984 Oct; 311(16):1019-29. PubMed ID: 6384779
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
    Okabe N; Inoue K; Mori R
    J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of autoimmune thyroid diseases].
    Andreoli M; Davoli C; Giacovazzo M
    Recenti Prog Med; 1980 Sep; 69(3):217-64. PubMed ID: 6256833
    [No Abstract]   [Full Text] [Related]  

  • 20. [Etiology and physiopathology of Basedow's disease].
    Akamizu T
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1131-5. PubMed ID: 9379088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.